Type A botulinum toxin has widened its medical variety of purposes, but the potential risk of creating antibodies boundaries the recurring use of high-dose injection. Other serotypes of botulinum toxin are now being investigated as handy solutions.The light (L) chain connect with distinctive proteins (synaptosomal associated protein (SNAP) 25, vesi